B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Brigatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Brigatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ceritinib
28 shared targets
asp
25 shared targets
neratinib
36 shared targets
bms
27 shared targets
danusertib
30 shared targets
azd
27 shared targets
midostaurin
55 shared targets
rebastinib
36 shared targets
cediranib
30 shared targets
mln
27 shared targets
Loading evidence profile...

This evidence profile for Brigatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.